ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag alzheimer s disease bioethics poetry disease medicine ecology

Notebook
The Scientist Staff | Mar 29, 1998 | 8 min read
Contents Moral Might Self-Validation More Alzheimer's Progress Broader Role For Mobile DNA Preferential Hearing Special Delivery Perfect Pitch Genes Imaging Dsylexia Date: March 30, 1998 A GUIDE TO ETHICS: Eric Meslin took over leadership of the National Bioethics Advisory Commission last month. MORAL MIGHT Eric M. Meslin, 36, has taken over leadership of the National Bioethics Advisory Commission (NBAC) in Rockville, Md. Harold T. Shapiro, NBAC's chairman and president of Princeton Univers
Biotech Faces Evolving Patent System
Douglas Steinberg | Mar 5, 2000 | 8 min read
Like medieval alchemists, modern biologists apply intricate, esoteric protocols to lowly matter, such as bacteria and rodents. Unlike alchemists, biologists successfully transmute these creatures into gold--disease-fighting pharmaceuticals and profits accruing from them. An indispensable ingredient in this dross-to-drug process is patent protection, which preserves monopoly and attracts investment. Unfortunately, the patent system isn't as ideal a catalyst as the chimerical philosopher's stone s
Cloning Capsized?
Ted Agres | Aug 19, 2001 | 10+ min read
Biopharmaceutical researchers fear how pending federal legislation outlawing the cloning of human cells will restrict their abilities to find cures for major degenerative diseases.1,2 Some also see lawmakers impinging on established nonhuman cloning techniques essential for the discovery of new drugs and therapies. The source of all this worry? The US House of Representatives passed July 31 by a wide margin a bill (H.R. 2505) sponsored by Reps. David Weldon (R-Fla.) and Bart Stupak (D-Mich.) th
Preimplantation Genetic Diagnosis: The Next Big Thing?
Ricki Lewis | Nov 12, 2000 | 9 min read
Courtesy of David Hill, ART Reproductive Center Inc.Two separated blastomeres subjected to FISH analysis to check the chromosomes. In early October, preimplantation genetic diagnosis (PGD) made headlines when a Colorado couple used assisted reproductive technology (ART) to have a baby named Adam, whose umbilical cord stem cells could cure his six-year-old sister Molly's Fanconi anemia.1 When Adam Nash was a ball of blastomere cells, researchers at the Reproductive Genetics Institute at Illinois

Run a Search

ADVERTISEMENT